DCBO Docebo Inc. IFRS
Services-Prepackaged Software · Nasdaq · SEC CIK 1829959 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY11.9%
TTM net income YoY40.3%
TTM EPS YoY48.8%
Revenue 3-yr CAGR19.3%
Net income 3-yr CAGR74.8%
Margins
Gross margin80.3%
Operating margin9.6%
Net margin15.5%
FCF margin11.2%
EBITDA margin10.9%
Returns
ROE56.9%
ROA18.9%
ROIC (approx.)—
Asset turnover1.22x
Leverage & solvency
Liabilities / assets64.1%
Debt / equity0.00x
Current ratio1.22x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio4.7%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $242.69M | $216.93M | $180.84M | $142.91M | $104.24M |
| Cost of revenue | $47.85M | $41.30M | $34.50M | $28.18M | $20.79M |
| Gross profit | $194.84M | $175.64M | $146.34M | $114.73M | $83.46M |
| R&D expense | $50.12M | $43.91M | $35.48M | $24.78M | $20.36M |
| SG&A expense | $34.70M | $32.59M | $33.79M | $30.18M | $28.44M |
| Operating income | $23.24M | $21.29M | -$3.71M | $4.18M | -$13.45M |
| Pretax income | $24.45M | $23.71M | $4.85M | $7.78M | -$13.43M |
| Income tax | -$13.07M | -$3.02M | $2.01M | $764,000 | $172,000 |
| Net income | $37.51M | $26.74M | $2.84M | $7.02M | -$13.60M |
| EBITDA | $26.42M | $24.68M | -$569,000 | $6.52M | -$11.43M |
| EPS (basic) | 1.31 | 0.88 | 0.09 | 0.21 | -0.41 |
| EPS (diluted) | 1.28 | 0.86 | 0.08 | 0.21 | -0.41 |
| Weighted avg. shares (diluted) | 29.37M | 30.99M | 33.68M | 34.04M | 32.87M |
| Balance sheet | |||||
| Cash & equivalents | $74.04M | $92.54M | $71.95M | $216.29M | $215.32M |
| Receivables | $55.21M | $45.57M | $41.77M | $37.53M | $27.68M |
| Current assets | $151.52M | $154.24M | $127.15M | $263.58M | $251.59M |
| PP&E, netmay include right-of-use assets (IFRS) | $2.04M | $2.00M | $2.11M | $2.62M | $2.65M |
| Goodwill | $14.54M | $13.85M | $14.25M | $5.98M | $5.30M |
| Intangibles | $1.03M | $1.67M | $2.40M | $1.15M | $1.58M |
| Total assets | $206.65M | $190.71M | $158.38M | $283.67M | $268.22M |
| Current liabilities | $123.80M | $128.60M | $100.65M | $84.36M | $69.27M |
| Short-term debt | — | — | — | — | $0 |
| Total liabilities | $132.56M | $132.95M | $107.65M | $91.46M | $77.57M |
| Shareholders' equity | $74.09M | $57.76M | $50.72M | $192.21M | $190.66M |
| Cash flow statement | |||||
| Operating cash flow | $28.17M | $29.25M | $15.96M | $2.29M | -$3.25M |
| Capital expenditure | $981,000 | $1.25M | $635,000 | $1.08M | $1.15M |
| Free cash flow | $27.19M | $28.00M | $15.33M | $1.21M | -$4.40M |
| Investing cash flow | -$1.84M | -$1.50M | -$9.52M | -$2.25M | -$1.15M |
| Financing cash flow | -$46.65M | -$6.84M | -$151.00M | $1.67M | $422,000 |
| Depreciation & amortization | $3.19M | $3.38M | $3.14M | $2.33M | $2.02M |
| Stock-based compensation | $6.00M | $7.33M | $6.05M | $4.71M | $2.26M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.